SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950123-03-002742
Filing Date
2003-03-12
Accepted
2003-03-12 09:24:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D y84286asc13d.txt SC 13D 19249
3 DEBENTURE PURCHASE AGREEMENT y84286aexv99w1.txt EX-99.1 227983
4 VOTING AGREEMENT y84286aexv99w2.txt EX-99.2 20684
5 OPTION AGREEMENTS y84286aexv99w3.txt EX-99.3 78798
  Complete submission text file 0000950123-03-002742.txt   348959
Mailing Address 695 N. PERRYVILLE ROAD ROCKFORD IL 61107
Business Address 1827 PACIFIC ST BROOKLYN NY 11233 7184677500
HALSEY DRUG CO INC/NEW (Subject) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-38110 | Film No.: 03600142
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HALSEY DRUG CO INC 1827 PACIFIC STREET BROOKLYN NY 11233
Business Address C/O HALSEY DRUG CO INC 1827 PACIFIC STREET BROOKLYN NY 11233
CLEMENS PETER A (Filed by) CIK: 0001056695 (see all company filings)